Evidence map›Paper›PMID 30940070›Full record

ArticleBMC microbiology2019

Lipopeptide mediated biocontrol activity of endophytic Bacillus subtilis against fungal phytopathogens.

Dibya Jyoti Hazarika, Gunajit Goswami, Trishnamoni Gautom, Assma Parveen, Pompi Das, Madhumita Barooah, Robin Chandra Boro

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Unveiling the Potential of EndophyticFoods (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Lipopeptide iturin CArchives of microbiology · 2025
    Article
  8. Two Strains of EndophyticIndian journal of microbiology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. AFrontiers in fungal biology · 2024
    Article
  14. Article
  15. The Extracellular Lipopeptides and Volatile Organic Compounds ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Suppression of Fusarium Wilt in Watermelon byJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dibya Jyoti HazarikaDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India.
Gunajit GoswamiDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India.
Trishnamoni GautomDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India.
Assma ParveenDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India.
Pompi DasDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India.
Madhumita BarooahDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India.
Robin Chandra BoroDepartment of Agricultural Biotechnology, Assam Agricultural University, 785013, Jorhat, India. robinboro@gmail.com.ORCID 0000-0002-0866-3357
Assam Agricultural University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of chemical fungicides against fungal pathogens adversely affects soil and plant health thereby resulting in overall environmental hazards. Therefore, biological source for obtaining antifungal agents is considered as an environment-friendly alternative for controlling fungal pathogens.

resultsIn this study, seven endophytic bacteria were isolated from sugarcane leaves and screened for its antifungal activity against 10 fungal isolates belonging to the genera Alternaria, Cochliobolus, Curvularia, Fusarium, Neodeightonia, Phomopsis and Saccharicola isolated from diseased leaves of sugarcane. Among the seven bacterial isolates, SCB-1 showed potent antagonistic activity against the tested fungi. Based on the phenotypic data, Fatty Acid Methyl Esters (FAME) and 16S rRNA gene sequence analysis, the isolate SCB-1 was identified as Bacillus subtilis. The bacterial isolate was screened negative for chitinase production; however, chloroform and methanol extracts of the bacterial culture caused significant inhibition in the growth of the fungal isolates on semisolid media. Volatile component assay showed highest inhibitory activity against Saccharicola bicolor (SC1.4). A PCR based study detected the presence of the genes involved in biosynthesis of surfactin, bacillaene, difficidin, macrolactins and fengycin. Mass spectrometric analysis of the bacterial extract detected the presence of antifungal lipopeptide surfactin, but other metabolites were not detected. The biocontrol activity of the bacterial isolate was established when bacterial pretreated mung bean seeds were able to resist Fusarium infection, however, the untreated seeds failed to germinate.

conclusionThe antifungal potential of isolate Bacillus subtilis SCB-1 was established against taxonomically diverse fungal pathogens including the genera Saccharicola, Cochliobolus, Alternaria and Fusarium. The potent antifungal compound surfactin as well as volatiles produced by the bacterial isolate could be responsible for its bio-control activity against fungal infections.

Indexed as

AntibiosisBiological Control AgentsBacillus subtilisEndophytesFungiFusariumLipopeptidesPeptides, CyclicPlant DiseasesPlantsRNA, Ribosomal, 16SBiological Control AgentsLipopeptidesPeptides, CyclicRNA, Ribosomal, 16Ssurfactin peptideAntifungal activityBacillus subtilisBiological controlFAMELC-MSSurfactin

Identifiers

PMID30940070
PMCPMC6444643
OpenAlexW2944379616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.